Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1013

1.

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.

Eyre TA, Lamanna N, Roeker LE, Ujjani CS, Hill BT, Barr PM, Lansigan E, Cheson BD, Yazdy M, Allan JN, Rhodes J, Schuster SJ, Nabhan C, Skarbnik A, Leslie L, Islam P, Whitaker K, Coombs CC, Tuncer HH, Pagel JM, Jacobs R, Winter AM, Bailey N, Sitlinger A, Schuh AH, Follows G, Fox CP, Brander DM, Shadman M, Mato AR.

Haematologica. 2020 Feb 20. pii: haematol.2019.241539. doi: 10.3324/haematol.2019.241539. [Epub ahead of print] No abstract available.

2.

Surface Dosimetry of Patients Undergoing Total Body Irradiation: A Retrospective Analysis for Quality Assurance.

Sengupta A, Wilke DR, Cherpak A, Chytyk-Praznik K, Schella J, Yewondwossen M, Allan J, Mulroy L.

Cureus. 2020 Feb 6;12(2):e6900. doi: 10.7759/cureus.6900.

3.

Bedtime Routines Intervention for Children (BRIC) using an automated text messaging system for behaviour change: study protocol for an early phase study.

Kitsaras G, Allan J, Pretty IA.

Pilot Feasibility Stud. 2020 Feb 6;6:14. doi: 10.1186/s40814-020-0562-y. eCollection 2020.

4.

From the President.

Allan J.

Australas Psychiatry. 2020 Feb;28(1):116. doi: 10.1177/1039856219895531. No abstract available.

PMID:
32013554
5.

Who is willing to participate in research? A screening model for an anxiety and depression trial in the epilepsy clinic.

Munger Clary HM, Croxton RD, Allan J, Lovato J, Brenes G, Snively BM, Wan M, Kimball J, Wong MH, O'Donovan CA, Conner K, Jones V, Duncan P.

Epilepsy Behav. 2020 Jan 27;104(Pt A):106907. doi: 10.1016/j.yebeh.2020.106907. [Epub ahead of print]

PMID:
32000099
6.

Randomised Control Trial Comparing Cypermethrin-Based Preparations in the Prevention of Infectious Bovine Keratoconjunctivitis in Cattle.

Allan J, Van Winden S.

Animals (Basel). 2020 Jan 22;10(2). pii: E184. doi: 10.3390/ani10020184.

7.

Loss of circadian gene Bmal1 in the collecting duct lowers blood pressure in male, but not female, mice.

Zhang D, Jin C, Obi IE, Rhoads MK, Soliman RH, Sedaka RS, Allan JM, Tao B, Speed JS, Pollock JS, Pollock DM.

Am J Physiol Renal Physiol. 2020 Jan 6. doi: 10.1152/ajprenal.00364.2019. [Epub ahead of print]

PMID:
31904281
8.

The host generalist phytopathogenic fungus Sclerotinia sclerotiorum differentially expresses multiple metabolic enzymes on two different plant hosts.

Allan J, Regmi R, Denton-Giles M, Kamphuis LG, Derbyshire MC.

Sci Rep. 2019 Dec 27;9(1):19966. doi: 10.1038/s41598-019-56396-w.

9.

From the President.

Allan J.

Australas Psychiatry. 2019 Dec;27(6):659. doi: 10.1177/1039856219886199. No abstract available.

PMID:
31842615
10.

Correction: Hotspots of human impact on threatened terrestrial vertebrates.

Allan JR, Watson JEM, Marco MD, O'Bryan CJ, Possingham HP, Atkinson SC, Venter O.

PLoS Biol. 2019 Dec 16;17(12):e3000598. doi: 10.1371/journal.pbio.3000598. eCollection 2019 Dec.

11.

Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications.

Arruga F, Bracciamà V, Vitale N, Vaisitti T, Gizzi K, Yeomans A, Coscia M, D'Arena G, Gaidano G, Allan JN, Furman RR, Packham G, Forconi F, Deaglio S.

Leukemia. 2019 Dec 13. doi: 10.1038/s41375-019-0680-9. [Epub ahead of print]

PMID:
31836851
12.

Correction: Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells.

Snyder CM, Davis-Poynter N, Farrell HE, Allan JE, Bonnett EL, Doom CM, Hill AB.

PLoS One. 2019 Dec 13;14(12):e0226705. doi: 10.1371/journal.pone.0226705. eCollection 2019.

13.

Outpatient psychosocial substance use treatments for young people: An overview of reviews.

Snowdon N, Allan J, Shakeshaft A, Rickwood D, Stockings E, Boland VC, Courtney RJ.

Drug Alcohol Depend. 2019 Dec 1;205:107582. doi: 10.1016/j.drugalcdep.2019.107582. Epub 2019 Sep 25.

PMID:
31778903
14.

Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.

Vijayakrishnan J, Qian M, Studd JB, Yang W, Kinnersley B, Law PJ, Broderick P, Raetz EA, Allan J, Pui CH, Vora A, Evans WE, Moorman A, Yeoh A, Yang W, Li C, Bartram CR, Mullighan CG, Zimmerman M, Hunger SP, Schrappe M, Relling MV, Stanulla M, Loh ML, Houlston RS, Yang JJ.

Nat Commun. 2019 Nov 25;10(1):5348. doi: 10.1038/s41467-019-13069-6.

15.

The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.

Eyre TA, Roeker LE, Fox CP, Gohill SH, Walewska R, Walter HS, Forconi F, Broom A, Arumainathan A, Brander DM, Allan JN, Schuster SJ, Hill BT, Lansigan F, Cheson BD, Lamanna N, Coombs CC, Barr PM, Skarbnik AP, Shadman M, Ujjani CS, Pearson L, Pagel JM, Jacobs R, Mato AR.

Br J Haematol. 2019 Nov 4. doi: 10.1111/bjh.16271. [Epub ahead of print]

PMID:
31682002
16.

Phenome-wide association analysis of LDL-cholesterol lowering genetic variants in PCSK9.

Schmidt AF, Holmes MV, Preiss D, Swerdlow DI, Denaxas S, Fatemifar G, Faraway R, Finan C, Valentine D, Fairhurst-Hunter Z, Hartwig FP, Horta BL, Hypponen E, Power C, Moldovan M, van Iperen E, Hovingh K, Demuth I, Norman K, Steinhagen-Thiessen E, Demuth J, Bertram L, Lill CM, Coassin S, Willeit J, Kiechl S, Willeit K, Mason D, Wright J, Morris R, Wanamethee G, Whincup P, Ben-Shlomo Y, McLachlan S, Price JF, Kivimaki M, Welch C, Sanchez-Galvez A, Marques-Vidal P, Nicolaides A, Panayiotou AG, Onland-Moret NC, van der Schouw YT, Matullo G, Fiorito G, Guarrera S, Sacerdote C, Wareham NJ, Langenberg C, Scott RA, Luan J, Bobak M, Malyutina S, Pająk A, Kubinova R, Tamosiunas A, Pikhart H, Grarup N, Pedersen O, Hansen T, Linneberg A, Jess T, Cooper J, Humphries SE, Brilliant M, Kitchner T, Hakonarson H, Carrell DS, McCarty CA, Lester KH, Larson EB, Crosslin DR, de Andrade M, Roden DM, Denny JC, Carty C, Hancock S, Attia J, Holliday E, Scott R, Schofield P, O'Donnell M, Yusuf S, Chong M, Pare G, van der Harst P, Said MA, Eppinga RN, Verweij N, Snieder H; Lifelines Cohort authors, Christen T, Mook-Kanamori DO; ICBP Consortium, Gustafsson S, Lind L, Ingelsson E, Pazoki R, Franco O, Hofman A, Uitterlinden A, Dehghan A, Teumer A, Baumeister S, Dörr M, Lerch MM, Völker U, Völzke H, Ward J, Pell JP, Meade T, Christophersen IE, Maitland-van der Zee AH, Baranova EV, Young R, Ford I, Campbell A, Padmanabhan S, Bots ML, Grobbee DE, Froguel P, Thuillier D, Roussel R, Bonnefond A, Cariou B, Smart M, Bao Y, Kumari M, Mahajan A, Hopewell JC, Seshadri S; METASTROKE Consortium of the ISGC, Dale C, Costa RPE, Ridker PM, Chasman DI, Reiner AP, Ritchie MD, Lange LA, Cornish AJ, Dobbins SE, Hemminki K, Kinnersley B, Sanson M, Labreche K, Simon M, Bondy M, Law P, Speedy H, Allan J, Li N, Went M, Weinhold N, Morgan G, Sonneveld P, Nilsson B, Goldschmidt H, Sud A, Engert A, Hansson M, Hemingway H, Asselbergs FW, Patel RS, Keating BJ, Sattar N, Houlston R, Casas JP, Hingorani AD.

BMC Cardiovasc Disord. 2019 Oct 29;19(1):240. doi: 10.1186/s12872-019-1187-z.

17.
18.

Recurrent Gastrointestinal Near-Tetraploid Diffuse Large B-Cell Lymphoma Causing Intussusception and Ileal Ulceration.

Mathews SN, Niec R, Mathew S, Allan JN, Crawford CV.

ACG Case Rep J. 2019 Jul 17;6(7):e00131. doi: 10.14309/crj.0000000000000131. eCollection 2019 Jul.

19.

Sustained proton pump inhibitor deprescribing among dyspeptic patients in general practice: a return to self-management through a programme of education and alginate rescue therapy. A prospective interventional study.

Coyle C, Symonds R, Allan J, Dawson S, Russell S, Smith A, Daff C, Kotze H.

BJGP Open. 2019 Oct 29;3(3). pii: bjgpopen19X101651. doi: 10.3399/bjgpopen19X101651. Print 2019 Oct.

20.

Collective Action and Effective Dialogue to Address Gender Bias in Medicine.

Gold JM, Allan JM, Ralston SL, Fromme HB, Desai AD.

J Hosp Med. 2019 Oct;14(10):630-632. doi: 10.12788/jhm.3331. No abstract available.

PMID:
31577221
21.

From the President.

Allan J.

Australas Psychiatry. 2019 Oct;27(5):536. doi: 10.1177/1039856219874607. No abstract available.

PMID:
31545085
22.

Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis.

Liu YC, Margolskee E, Allan JN, Mathew S, Bhavsar E, Casano J, Orazi A, Furman RR, Geyer JT.

Mod Pathol. 2019 Sep 2. doi: 10.1038/s41379-019-0356-z. [Epub ahead of print]

PMID:
31477813
23.

Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications.

Arruga F, Bracciamà V, Vitale N, Vaisitti T, Gizzi K, Yeomans A, Coscia M, D'Arena G, Gaidano G, Allan JN, Furman RR, Packham G, Forconi F, Deaglio S.

Leukemia. 2020 Feb;34(2):462-477. doi: 10.1038/s41375-019-0571-0. Epub 2019 Aug 29. Erratum in: Leukemia. 2019 Dec 13;:.

PMID:
31467429
24.

Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics.

Speedy HE, Beekman R, Chapaprieta V, Orlando G, Law PJ, Martín-García D, Gutiérrez-Abril J, Catovsky D, Beà S, Clot G, Puiggròs M, Torrents D, Puente XS, Allan JM, López-Otín C, Campo E, Houlston RS, Martín-Subero JI.

Nat Commun. 2019 Aug 9;10(1):3615. doi: 10.1038/s41467-019-11582-2.

25.

Tracking snacking in real time: Time to look at individualised patterns of behaviour.

Allan J, McMinn D, Powell D.

Nutr Health. 2019 Sep;25(3):179-184. doi: 10.1177/0260106019866099. Epub 2019 Jul 26.

PMID:
31347450
26.

Pulmonary Artery Resection During Lung Resection for Malignancy.

Madariaga MLL, Geller A, Lanuti M, Ott H, Allan JS, Donahue DM, Mathisen DJ, Wright CD, Gaissert HA.

Ann Thorac Surg. 2019 Dec;108(6):1692-1700. doi: 10.1016/j.athoracsur.2019.05.079. Epub 2019 Jul 20.

PMID:
31336066
27.

Does self-efficacy moderate the effect of gambling advertising on problem gambling behaviors?

Quinn CA, Archibald K, Nykiel L, Pocuca N, Hides L, Allan J, Moloney G.

Psychol Addict Behav. 2019 Aug;33(5):503-509. doi: 10.1037/adb0000485. Epub 2019 Jul 11.

PMID:
31294579
28.

Reducing drug and alcohol use and improving well-being for Indigenous and non-Indigenous Australians using the Community Reinforcement Approach: A feasibility and acceptability study.

Calabria B, Shakeshaft AP, Clifford A, Stone C, Clare PJ, Allan J, Bliss D.

Int J Psychol. 2020 Jan;55 Suppl 1:88-95. doi: 10.1002/ijop.12603. Epub 2019 Jul 5.

PMID:
31273788
29.

The effectiveness of residential treatment services for individuals with substance use disorders: A systematic review.

de Andrade D, Elphinston RA, Quinn C, Allan J, Hides L.

Drug Alcohol Depend. 2019 Aug 1;201:227-235. doi: 10.1016/j.drugalcdep.2019.03.031. Epub 2019 Jun 20.

PMID:
31254749
30.

Midwives' perceptions of women's mobile phone use and impact on care in birth suite.

Lewis L, Barnes C, Allan J, Roberts L, Lube D, Hauck YL.

Midwifery. 2019 Sep;76:142-147. doi: 10.1016/j.midw.2019.06.002. Epub 2019 Jun 3.

PMID:
31207448
31.

Evaluation of a PGP3 ELISA for surveillance of the burden of Chlamydia infection in women from Australia and Samoa.

Mazraani R, Timms P, Hill PC, Suaalii-Sauni T, Niupulusu T, Temese SVA, Iosefa-Siitia L, Auvaa L, Tapelu SA, Motu MF, Righarts A, Walsh MS, Rombauts L, Allan JA, Horner P, Huston WM.

Pathog Dis. 2019 Apr 1;77(3). pii: ftz031. doi: 10.1093/femspd/ftz031.

32.

From the President.

Allan J.

Australas Psychiatry. 2019 Jun;27(3):316. doi: 10.1177/1039856219851598. No abstract available.

PMID:
31189365
33.

Achieving Self-Directed Integrated Cancer Aftercare (ASICA) in melanoma: protocol for a randomised patient-focused pilot trial of delivering the ASICA intervention as a means to earlier detection of recurrent and second primary melanoma.

Murchie P, Masthoff J, Walter FM, Rahman K, Allan JL, Burrows N, Proby C, Lee AJ, Johnston M, Durrani A, Depasquale I, Brant B, Neilson A, Meredith F, Treweek S, Hall S, McDonald A.

Trials. 2019 Jun 3;20(1):318. doi: 10.1186/s13063-019-3453-x.

34.

Purposeful Outdoor Learning Empowers Children to Deal with School Transitions.

Slee V, Allan JF.

Sports (Basel). 2019 May 31;7(6). pii: E134. doi: 10.3390/sports7060134.

35.

A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.

Martin P, Ruan J, Furman R, Rutherford S, Allan J, Chen Z, Huang X, DiLiberto M, Chen-Kiang S, Leonard JP.

Leuk Lymphoma. 2019 Dec;60(12):2917-2921. doi: 10.1080/10428194.2019.1612062. Epub 2019 May 23.

PMID:
31120355
36.

It's not all about the CNS. High dose methotrexate in DLBCL.

Allan JN, Van Besien K.

Leuk Lymphoma. 2019 Aug;60(8):1845-1847. doi: 10.1080/10428194.2019.1613544. Epub 2019 May 23. No abstract available.

PMID:
31120336
37.
38.

A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL.

Mato AR, Roeker LE, Eyre TA, Nabhan C, Lamanna N, Hill BT, Brander DM, Barr PM, Lansigan F, Cheson BD, Singavi AK, Yazdy MS, Shah NN, Allan JN, Bhavsar EB, Rhodes J, Kennard K, Schuster SJ, Williams AM, Skarbnik AP, Goy AH, Goodfriend JM, Dorsey C, Coombs CC, Tuncer H, Ujjani CS, Jacobs R, Winter AM, Pagel JM, Bailey N, Schuh A, Shadman M, Sitlinger A, Weissbrot H, Muralikrishnan S, Zelenetz A, Kirkwood AA, Fox CP.

Blood Adv. 2019 May 28;3(10):1568-1573. doi: 10.1182/bloodadvances.2019000180.

39.

Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia.

Gaiti F, Chaligne R, Gu H, Brand RM, Kothen-Hill S, Schulman RC, Grigorev K, Risso D, Kim KT, Pastore A, Huang KY, Alonso A, Sheridan C, Omans ND, Biederstedt E, Clement K, Wang L, Felsenfeld JA, Bhavsar EB, Aryee MJ, Allan JN, Furman R, Gnirke A, Wu CJ, Meissner A, Landau DA.

Nature. 2019 May;569(7757):576-580. doi: 10.1038/s41586-019-1198-z. Epub 2019 May 15.

40.

Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.

Dalbeth N, Billington K, Doyle A, Frampton C, Tan P, Aati O, Allan J, Drake J, Horne A, Stamp LK.

Arthritis Rheumatol. 2019 Oct;71(10):1739-1746. doi: 10.1002/art.40929. Epub 2019 Aug 12.

PMID:
31081595
41.

Global citizens.

Porteous D, Morgan D, Solomon J, Platt A, Allan J, Shao CHJ, Conner T.

Br J Nurs. 2019 May 9;28(9):574-577. doi: 10.12968/bjon.2019.28.9.574.

PMID:
31070961
42.

Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL.

Pastore A, Gaiti F, Lu SX, Brand RM, Kulm S, Chaligne R, Gu H, Huang KY, Stamenova EK, Béguelin W, Jiang Y, Schulman RC, Kim KT, Alonso A, Allan JN, Furman RR, Gnirke A, Wu CJ, Melnick AM, Meissner A, Bernstein BE, Abdel-Wahab O, Landau DA.

Nat Commun. 2019 Apr 23;10(1):1874. doi: 10.1038/s41467-019-09645-5.

43.

The many length scales of DNA packaging.

Gilbert N, Allan J.

Essays Biochem. 2019 Apr 23;63(1):1-4. doi: 10.1042/EBC20190040. Print 2019 Apr 23.

PMID:
31015379
44.

Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice.

Roeker LE, Fox CP, Eyre TA, Brander DM, Allan JN, Schuster SJ, Nabhan C, Hill BT, Shah NN, Lansigan F, Yazdy M, Cheson BD, Lamanna N, Singavi AK, Coombs CC, Barr PM, Skarbnik AP, Shadman M, Ujjani CS, Tuncer HH, Winter AM, Rhodes J, Dorsey C, Morse H, Kabel C, Pagel JM, Williams AM, Jacobs R, Goy A, Muralikrishnan S, Pearson L, Sitlinger A, Bailey N, Schuh A, Kirkwood AA, Mato AR.

Clin Cancer Res. 2019 Jul 15;25(14):4264-4270. doi: 10.1158/1078-0432.CCR-19-0361. Epub 2019 Apr 19.

PMID:
31004001
45.

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

Martinez-Soria N, McKenzie L, Draper J, Ptasinska A, Issa H, Potluri S, Blair HJ, Pickin A, Isa A, Chin PS, Tirtakusuma R, Coleman D, Nakjang S, Assi S, Forster V, Reza M, Law E, Berry P, Mueller D, Osborne C, Elder A, Bomken SN, Pal D, Allan JM, Veal GJ, Cockerill PN, Wichmann C, Vormoor J, Lacaud G, Bonifer C, Heidenreich O.

Cancer Cell. 2019 Apr 15;35(4):705. doi: 10.1016/j.ccell.2019.03.012. No abstract available.

46.

Navigating the complexities of coordinated conservation along the river Nile.

Allan JR, Levin N, Jones KR, Abdullah S, Hongoh J, Hermoso V, Kark S.

Sci Adv. 2019 Apr 3;5(4):eaau7668. doi: 10.1126/sciadv.aau7668. eCollection 2019 Apr.

47.

Increased demand for amphetamine treatment in rural Australia.

Allan J, Ip RHL, Kemp M, Snowdon N.

Addict Sci Clin Pract. 2019 Apr 1;14(1):13. doi: 10.1186/s13722-019-0144-6.

48.

The process of change for people with cognitive impairment in a residential rehabilitation program for substance problems: a phenomenographical analysis.

Allan J, Collings S, Munro A.

Subst Abuse Treat Prev Policy. 2019 Mar 29;14(1):13. doi: 10.1186/s13011-019-0200-y.

49.

Clinical decisions and time since rest break: An analysis of decision fatigue in nurses.

Allan JL, Johnston DW, Powell DJH, Farquharson B, Jones MC, Leckie G, Johnston M.

Health Psychol. 2019 Apr;38(4):318-324. doi: 10.1037/hea0000725.

PMID:
30896218
50.

Hotspots of human impact on threatened terrestrial vertebrates.

Allan JR, Watson JEM, Di Marco M, O'Bryan CJ, Possingham HP, Atkinson SC, Venter O.

PLoS Biol. 2019 Mar 12;17(3):e3000158. doi: 10.1371/journal.pbio.3000158. eCollection 2019 Mar. Erratum in: PLoS Biol. 2019 Dec 16;17(12):e3000598.

Supplemental Content

Support Center